Besides, there was a negative correlation between GHET1 expression and survival time in gastric cancer [10], breast cancer [15], esophageal squamous cell carcinoma [17], bladder cancer [19], and head and neck cancer [20]. Here, GHET1 is linked to urinary bladder cancer.